|
|
 |
|
Viewing report
|
|
|
|
The European Generics Outlook: A Country-By-Country Analysis Of Developing Market Opportunities And Revenue Defense Strategies
Business Insights, April 2003, Pages: 190
The European generic marketplace is perplexing and complicated, full of contradictions and inconsistencies - manufacturers of generic drugs are presented with unprecedented opportunities as large numbers of brand name products lose their patent protection. This is placing greater pressures than ever on multinationals to search for ways to extend their products’ patents and defend their market share. This management report fcritically analyzes the changing market conditions and the impact of these opportunities on the generics industry and multinational R& D companies. 'The European Generics Outlook: A country-by-country analysis of developing market opportunities and revenue defense strategies’, assesses the drivers and inhibitors of generics market growth within 15 European markets. The report provides detailed insights into European market dynamics, and explores strategies for survival for generic companies and defense strategies for multinationals' branded drugs. This report will enable you to perfect your generics strategy and yield the greatest return from your investment.
Hot issues covered in this report:
- Latest European legislation: Legislative changes discussed in the European Parliament at the end of 2002 could potentially have a major effect on generic expansion if they remove some of the legal and regulatory barriers.
- Contentious issues: Some of the topics covered by these pending changes in the Codified Directive constitute a major battleground between the generic and R& D sides as each lobbies for the proposals to be amended in their favor before the legislation is finalized, possibly in 2003.
- Threat to German generics: The German generic industry faces a potentially fatal price meltdown following the introduction of a modification to the reference pricing scheme that threatens to push prices into a downward spiral.
- Incentives to promote generics in Mediterranean countries: Countries in the southern part of Europe have now realized the potential savings offered by generics and have introduced measures such as reference pricing and substitution in 2002 with more legislation planned for 2003.
Why you should order your copy today:
- Examine the leading companies, products and strategies that are fuelling the growth and value of the generics industry.
- Review pricing, distribution and regulatory issues driving and/or restricting generics in 15 European markets.
- Spot the companies that have the potential to become generic superpowers, assess their impact on your company and develop counter strategies if necessary.
- Analyze factors critical for generic expansion and understand why generic penetration rates vary.
- Quantify future growth areas within different European markets (including the UK, France, Germany and Italy) to support the planning and formulation of your competitive strategies.
The answers to your questions:
- What will the generic growth markets be in the next 10 years?
- Which companies will become the key players?
- What roles will big pharma and biotech companies play in the future of the generics industry?
- Which countries are introducing measures to promote generics?
- What is constraining generic expansion in some countries?
- What is the future outlook for the mature generic markets?
- What European legislative changes are in the pipeline?
Customers who bought this item also bought
European Generic Drug Market Potential
Generic Series: An Introduction To The Canadian Generics Market - Key Trends And Leading Companies Shaping The Market
Emerging Generic Drug Markets in Europe
Generic Handbook: A Guide to the Generic Drug Industry in the US, 2007 Edition
GenericHandbook - A Guide to the Generic Drug Industry in the US
The World Generic Market Report 2008
Emerging Generic Pharmaceuticals Markets in Europe
Generic Strategies in Emerging Markets
Generics Series: Key trends and events in the 7 major markets
Generic Drug Market in Canada
US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts
Generic Series: Benchmarking Patent Expiries - Key Factors Affecting Brand Erosion At Patent Expiry
|
|
|
|
